Survey among healthcare professionals (neurologists treating patients with MS along with MS specialist nurses) and patients in selected European countries plus Canada to evaluate the knowledge required for the safe use of Mayzent (siponimod)

22/12/2021
18/12/2025
EU PAS number:
EUPAS44782
Study
Finalised
Documents
Study protocol
Initial protocol
English (569.96 KB - PDF) View document
Updated protocol
English (400.87 KB - PDF) View document
Study results
No information provided.
Study report
Study report
English (1.31 MB - PDF) View document
ENCePP Seal
No information provided.